Boyd, Michael R.
LLC,
United States
2025 Rank: 93489
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 332 out of 112089 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 93489 | 102075 |
| Total Cites | 1223 | 1239 |
| H-index | 10 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 96 | 99 |
| Number of Single+First+Last Authored Papers | 312 | 312 |
| Total Cites to Single+First+Last Authored Papers | 1050 | 1058 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 984 | 986 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.26 |
| Self-Citation Percentage |
1.29%
|
|
Boyd, Michael R.
ADT PHARMACEUTICALS, LLC,
United States
2024 Rank: 38149
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 126 out of 105998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38149 | 43377 |
| Total Cites | 1318 | 1335 |
| H-index | 13 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 107 | 110 |
| Number of Single+First+Last Authored Papers | 312 | 312 |
| Total Cites to Single+First+Last Authored Papers | 1098 | 1110 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1019 | 1023 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.30 |
| Self-Citation Percentage |
1.27%
|
|
Boyd, Michael R.
ADT PHARMACEUTICALS, LLC,
United States
2023 Rank: 38765
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 125 out of 99369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38765 | 44436 |
| Total Cites | 1387 | 1410 |
| H-index | 14 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 123 | 125 |
| Number of Single+First+Last Authored Papers | 312 | 312 |
| Total Cites to Single+First+Last Authored Papers | 1180 | 1189 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1102 | 1111 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.27 |
| Self-Citation Percentage |
1.63%
|
|
Boyd, Michael R.
National Cancer Institute (NCI),
United States
2022 Rank: 62670
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 190 out of 94672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62670 | 73397 |
| Total Cites | 1597 | 1615 |
| H-index | 14 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 95 | 97 |
| Number of Single+First+Last Authored Papers | 312 | 312 |
| Total Cites to Single+First+Last Authored Papers | 1350 | 1363 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1235 | 1242 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.30 |
| Self-Citation Percentage |
1.11%
|
|
Boyd, Michael R.
ADT PHARMACEUTICALS, LLC,
United States
2021 Rank: 50019
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 148 out of 88725 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 50019 | 59253 |
| Total Cites | 2408 | 2434 |
| H-index | 17 | 17 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 132 | 133 |
| Number of Single+First+Last Authored Papers | 312 | 312 |
| Total Cites to Single+First+Last Authored Papers | 2014 | 2026 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1938 | 1950 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.25 |
| Self-Citation Percentage |
1.07%
|
|
Boyd, Michael R.
National Cancer Institute,
United States
2020 Rank: 48955
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 148 out of 80622 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 48955 | 56840 |
| Total Cites | 1884 | 1932 |
| H-index | 14 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 88 | 94 |
| Number of Single+First+Last Authored Papers | 312 | 312 |
| Total Cites to Single+First+Last Authored Papers | 1560 | 1586 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1555 | 1562 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.24 |
| Self-Citation Percentage |
2.48%
|
|